Healthcare provider profile · identity verified

James Henry Blanton, MD

Internal Medicine · HOOVER, AL · NPI 1992810345

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	443	60
Eliquis	Apixaban	349	29
Levothyroxine Sodium	Levothyroxine Sodium	334	42
Trazodone Hcl	Trazodone Hcl	264	41
Furosemide	Furosemide	255	38
Amlodipine Besylate	Amlodipine Besylate	246	38
Potassium Chloride	Potassium Chloride	242	34
Quetiapine Fumarate	Quetiapine Fumarate	241	33
Mirtazapine	Mirtazapine	238	47
Buspirone Hcl	Buspirone Hcl	194	29
Pantoprazole Sodium	Pantoprazole Sodium	194	40
Sertraline Hcl	Sertraline Hcl	162	26
Donepezil Hcl	Donepezil Hcl	155	27
Famotidine	Famotidine	147	20
Gabapentin	Gabapentin	135	23
Losartan Potassium	Losartan Potassium	134	21
Memantine Hcl	Memantine Hcl	134	21
Levetiracetam	Levetiracetam	107	13
Metoprolol Succinate	Metoprolol Succinate	104	12
Lisinopril	Lisinopril	99	18
Carvedilol	Carvedilol	98	13
Escitalopram Oxalate	Escitalopram Oxalate	98	19
Tamsulosin Hcl	Tamsulosin Hcl	96	22
Metoprolol Tartrate	Metoprolol Tartrate	90	14
Montelukast Sodium	Montelukast Sodium	90	11
Divalproex Sodium	Divalproex Sodium	89	13
Tramadol Hcl	Tramadol Hcl	89	26
Omeprazole	Omeprazole	88	17
Metformin Hcl	Metformin Hcl	82	13
Lorazepam	Lorazepam	79	17
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	78	15
Pravastatin Sodium	Pravastatin Sodium	78	11
Simvastatin	Simvastatin	77	12
Risperidone	Risperidone	75	12
Duloxetine Hcl	Duloxetine Hcl	72	15
Hydrochlorothiazide	Hydrochlorothiazide	69	suppressed
Hydralazine Hcl	Hydralazine Hcl	57	11
Citalopram Hbr	Citalopram Hydrobromide	54	suppressed
Trulicity	Dulaglutide	54	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	53	suppressed
Ramipril	Ramipril	49	suppressed
Myrbetriq	Mirabegron	48	suppressed
Oxcarbazepine	Oxcarbazepine	48	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	46	14
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	45	suppressed
Olanzapine	Olanzapine	45	suppressed
Baclofen	Baclofen	44	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	44	suppressed
Rexulti	Brexpiprazole	44	suppressed
Clopidogrel	Clopidogrel Bisulfate	43	suppressed
Spironolactone	Spironolactone	42	suppressed
Allopurinol	Allopurinol	40	suppressed
Bumetanide	Bumetanide	40	suppressed
Linzess	Linaclotide	37	suppressed
Prednisone	Prednisone	36	suppressed
Sucralfate	Sucralfate	36	suppressed
Aripiprazole	Aripiprazole	34	suppressed
Benztropine Mesylate	Benztropine Mesylate	34	suppressed
Pregabalin	Pregabalin	34	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	33	25
Prazosin Hcl	Prazosin Hcl	33	suppressed
Amiodarone Hcl	Amiodarone Hcl	31	suppressed
Bupropion Xl	Bupropion Hcl	31	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	31	suppressed
Ropinirole Hcl	Ropinirole Hcl	31	suppressed
Propranolol Hcl	Propranolol Hcl	29	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	28	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	28	suppressed
Methotrexate	Methotrexate Sodium	28	suppressed
Naproxen	Naproxen	27	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	27	22
Esomeprazole Magnesium	Esomeprazole Magnesium	26	suppressed
Fluconazole	Fluconazole	26	17
Humalog	Insulin Lispro	25	suppressed
Bupropion Hcl Sr	Bupropion Hcl	24	suppressed
Glimepiride	Glimepiride	24	suppressed
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	24	suppressed
Brilinta	Ticagrelor	23	suppressed
Ezetimibe	Ezetimibe	23	suppressed
Jardiance	Empagliflozin	23	suppressed
Levemir	Insulin Detemir	23	suppressed
Topiramate	Topiramate	23	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	23	suppressed
Lacosamide	Lacosamide	22	suppressed
Clonazepam	Clonazepam	21	suppressed
Doxepin Hcl	Doxepin Hcl	21	suppressed
Ceftriaxone	Ceftriaxone Sodium	20	11
Chlorthalidone	Chlorthalidone	20	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	20	suppressed
Lamotrigine	Lamotrigine	20	suppressed
Oxycodone Hcl	Oxycodone Hcl	20	suppressed
Timolol Maleate	Timolol Maleate	20	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	20	suppressed
Acyclovir	Acyclovir	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	19	suppressed
Entresto	Sacubitril/Valsartan	19	suppressed
Midodrine Hcl	Midodrine Hcl	19	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	19	suppressed
Gemtesa	Vibegron	18	suppressed
Latanoprost	Latanoprost	18	suppressed
Nystop	Nystatin	18	suppressed
Valsartan	Valsartan	18	suppressed
Estradiol	Estradiol	17	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	17	suppressed
Primidone	Primidone	17	suppressed
Cephalexin	Cephalexin	16	suppressed
Glipizide	Glipizide	16	suppressed
Lithium Carbonate	Lithium Carbonate	16	suppressed
Mupirocin	Mupirocin	16	suppressed
Ondansetron Hcl	Ondansetron Hcl	16	suppressed
Novolog	Insulin Aspart	15	suppressed
Raloxifene Hcl	Raloxifene Hcl	15	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	14	suppressed
Fluticasone Propionate	Fluticasone Propionate	14	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	14	suppressed
Methocarbamol	Methocarbamol	14	suppressed
Paliperidone Er	Paliperidone	14	suppressed
Risperdal Consta	Risperidone Microspheres	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Calcitriol	Calcitriol	13	suppressed
Divalproex Sodium Er	Divalproex Sodium	13	suppressed
Lidocaine Hcl	Lidocaine Hcl	13	suppressed
Metformin Hcl Er	Metformin Hcl	13	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Captopril	Captopril	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Digoxin	Digoxin	12	suppressed
Finasteride	Finasteride	12	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	12	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	12	suppressed
Meloxicam	Meloxicam	12	suppressed
Spiriva Respimat	Tiotropium Bromide	12	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	11	suppressed
Levofloxacin	Levofloxacin	11	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	11	suppressed
Nuedexta	Dextromethorphan Hbr/Quinidine	11	suppressed
Scopolamine	Scopolamine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error